The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia JD McConnell, CG Roehrborn, OM Bautista, GL Andriole Jr, CM Dixon, ... New England Journal of Medicine 349 (25), 2387-2398, 2003 | 2825 | 2003 |
Radical prostatectomy versus observation for localized prostate cancer TJ Wilt, MK Brawer, KM Jones, MJ Barry, WJ Aronson, S Fox, JR Gingrich, ... New England Journal of Medicine 367 (3), 203-213, 2012 | 2259 | 2012 |
Update on AUA guideline on the management of benign prostatic hyperplasia KT McVary, CG Roehrborn, AL Avins, MJ Barry, RC Bruskewitz, ... The Journal of urology 185 (5), 1793-1803, 2011 | 1581 | 2011 |
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia JD McConnell, R Bruskewitz, P Walsh, G Andriole, M Lieber, ... New England Journal of Medicine 338 (9), 557-563, 1998 | 1560 | 1998 |
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ... Journal of Clinical Oncology 25 (15), 2035-2041, 2007 | 1090 | 2007 |
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study CG Roehrborn, P Siami, J Barkin, R Damião, K Major-Walker, I Nandy, ... European urology 57 (1), 123-131, 2010 | 1046 | 2010 |
Female stress urinary incontinence clinical guidelines panel summary report on surgical management of female stress urinary incontinence GE Leach, RR Dmochowski, R Appell, JG Blaivas, HR Hadley, KM Luber, ... The Journal of urology 158 (3), 875-880, 1997 | 990 | 1997 |
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia CG Roehrborn, P Boyle, JC Nickel, K Hoefner, G Andriole Urology 60 (3), 434-441, 2002 | 920 | 2002 |
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients MC Hall, S Womack, AI Sagalowsky, T Carmody, MD Erickstad, ... Urology 52 (4), 594-601, 1998 | 846 | 1998 |
Benign prostatic hyperplasia: an overview CG Roehrborn Reviews in urology 7 (Suppl 9), S3, 2005 | 835* | 2005 |
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy AJ Stephenson, SF Shariat, MJ Zelefsky, MW Kattan, EB Butler, BS Teh, ... Jama 291 (11), 1325-1332, 2004 | 763 | 2004 |
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial SA Kaplan, CG Roehrborn, ES Rovner, M Carlsson, T Bavendam, Z Guan Jama 296 (19), 2319-2328, 2006 | 744 | 2006 |
Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials P Boyle, AL Gould, CG Roehrborn Urology 48 (3), 398-405, 1996 | 661 | 1996 |
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses Y Lotan, CG Roehrborn Urology 61 (1), 109-118, 2003 | 630 | 2003 |
A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder CR Chapple, CG Roehrborn European urology 49 (4), 651-659, 2006 | 592 | 2006 |
The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial JC Nickel, CG Roehrborn, MP O'Leary, DG Bostwick, MC Somerville, ... European urology 54 (6), 1379-1384, 2008 | 558 | 2008 |
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia VJM Verhoeven, PG Hysi, R Wojciechowski, Q Fan, JA Guggenheim, ... Nature genetics 45 (3), 314-318, 2013 | 557 | 2013 |
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia CG Roehrborn, P Boyle, AL Gould, J Waldstreicher Urology 53 (3), 581-589, 1999 | 554 | 1999 |
Pathology of benign prostatic hyperplasia CG Roehrborn International journal of impotence research 20 (3), S11-S18, 2008 | 530 | 2008 |
The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year … CG Roehrborn, P Siami, J Barkin, R Damião, K Major-Walker, B Morrill, ... The Journal of urology 179 (2), 616-621, 2008 | 502 | 2008 |